Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeonsโ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
์ข
๋ชฉ ์ฝ๋ AORT
ํ์ฌ ์ด๋ฆArtivion Inc
์์ฅ์ผFeb 12, 1993
CEOMackin (James Patrick)
์ง์ ์1600
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃFeb 12
์ฃผ์1655 Roberts Boulevard N W
๋์KENNESAW
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ30144
์ ํ17704193355
์น์ฌ์ดํธhttps://artivion.com/
์ข
๋ชฉ ์ฝ๋ AORT
์์ฅ์ผFeb 12, 1993
CEOMackin (James Patrick)